Aisling Capital as of Sept. 30, 2018
Portfolio Holdings for Aisling Capital
Aisling Capital holds 9 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 75.3 | $348M | 2.0M | 170.83 | |
| Aimmune Therapeutics | 11.7 | $54M | 2.0M | 27.28 | |
| Adma Biologics (ADMA) | 4.8 | $22M | 3.6M | 6.21 | |
| Viewray (VRAYQ) | 3.5 | $16M | 1.7M | 9.36 | |
| Transenterix | 3.0 | $14M | 2.4M | 5.80 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.0 | $4.5M | 1.0M | 4.40 | |
| Chimerix (CMRX) | 0.4 | $1.8M | 473k | 3.89 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.2 | $1.1M | 2.5M | 0.44 | |
| Pernix Therapeutics Holdings | 0.0 | $202k | 210k | 0.96 |
